Hepatic FcRn regulates albumin homeostasis and susceptibility to liver injury
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Significance: Neonatal crystallizable fragment receptor (FcRn) regulates immunity and homeostasis of the two most abundant circulating proteins, IgG and albumin. FcRn is expressed in hepatocytes, but hepatic FcRn function is unknown. We show that hepatic FcRn regulates albumin biodistribution. Absence of FcRn in the liver leads to hypoalbuminemia by preventing efficient albumin delivery into the circulation, causing albumin retention within hepatocytes and increasing biliary albumin excretion. Blockade of albumin–FcRn interactions protects liver from damage induced by acetaminophen, a hepatotoxin. This protection results from hepatocyte accumulation of albumin, which scavenges superoxide radicals, and from the redirection of albumin-bound acetaminophen into the bile. Therefore, FcRn-mediated homeostatic distribution of albumin into the bloodstream renders hepatocytes susceptible to acute hepatotoxin exposure, and inhibition of FcRn in the hepatocyte is protective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Postic, C., Shiota, M., Niswender, K. D., Jetton, T. L., Chen, Y., Moates, J. M., Shelton, K. D., Lindner, J., Cherrington, A. D., & Magnuson, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.305 · Cited by 1,302
Levitt, D., & Levitt, M. (2016) · International Journal of General Medicine · doi:10.2147/ijgm.s102819 · Cited by 763 · cited 2×
“In accordance with human and mouse studies in which hypoalbuminemia results in an increased rate of albumin synthesis (20, 53), we detected greater intracellular albumin content in FcRn-deficient hepatocytes and upon antibody-mediated albumin–FcRn blockade.”
BackgroundChaudhury, C., Mehnaz, S., Robinson, J. M., Hayton, W. L., Pearl, D. K., Roopenian, D. C., & Anderson, C. L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021829 · Cited by 640 · cited 4×
“because the half-life and the steady-state concentration of albumin are decreased in FcRn-deficient individuals and animals, it was proposed that FcRn diverts not only IgG but also albumin from intracellular degradation, prolonging the life spans of both proteins (3, 11, 14, 15).”
BackgroundResultInfluentialSelf-citationC-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity
Gunawan, B. K., Liu, Z., Han, D., Hanawa, N., Gaarde, W. A., & Kaplowitz, N. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.045 · Cited by 471
Self-citationLauterburg, B. H., Corcoran, G. B., & Mitchell, J. R. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110853 · Cited by 358 · cited 4×
“E2866 | www.pnas.org/cgi/doi/10.1073/pnas.1618291114 Pyzik et al. In a separate experimental cohort with sublethal APAP administration (400 mg/kg), we further compared the effectiveness of albumin–FcRn blockade to treatment with the standard clinical antidote, N-acetylcysteine (NAC), which reduces APAP toxicity by rep…”
MethodInfluentialMechanisms of drug-induced liver injury
Yuan, L., & Kaplowitz, N. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.07.002 · Cited by 322
Self-citationRaghavan, M., Bonagura, V. R., Morrison, S. L., & Bjorkman, P. J. (1995) · Biochemistry · doi:10.1021/bi00045a005 · Cited by 317
Albumin Binding to FcRn: Distinct from the FcRn−IgG Interaction
Chaudhury, C., Brooks, C. L., Carter, D. C., Robinson, J. M., & Anderson, C. L. (2006) · Biochemistry · doi:10.1021/bi052628y · Cited by 290 · cited 3×
“because the half-life and the steady-state concentration of albumin are decreased in FcRn-deficient individuals and animals, it was proposed that FcRn diverts not only IgG but also albumin from intracellular degradation, prolonging the life spans of both proteins (3, 11, 14, 15).”
BackgroundEvidence to support the cellular mechanism involved in serum IgG homeostasis in humans
Ward, E. S. (2003) · International Immunology · doi:10.1093/intimm/dxg018 · Cited by 216 · cited 1×
“In the case of monomeric IgG, binding to FcRn in acidic endosomes of endothelial and hematopoietic cells serves to recycle IgG to the cell surface where it is released into the circulation at physiologic pH (4, 5).”
BackgroundMontoyo, H. P., Vaccaro, C., Hafner, M., Ober, R. J., Mueller, W., & Ward, E. S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810796106 · Cited by 211 · cited 4×
“To determine whether the liver itself was responsible for the hypoalbuminemia and albumin loss into the bile observed in the total absence of FcRn, we generated AlbFcgrt mice by crossing Fcgrt mice (16) with mice expressing the Cre recombinase under control of the albumin enhancer/promoter [B6.”
BackgroundMethodInfluential
Cited by
The Neonatal Fc Receptor (FcRn): A Misnomer?
Pyzik, M., Sand, K. M. K., Hubbard, J. J., Andersen, J. T., Sandlie, I., & Blumberg, R. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01540 · Cited by 429
Self-citationAlbumin in decompensated cirrhosis: new concepts and perspectives
Bernardi, M., Angeli, P., Claria, J., Moreau, R., Gines, P., Jalan, R., Caraceni, P., Fernandez, J., Gerbes, A. L., O'Brien, A. J., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-318843 · Cited by 357
The therapeutic age of the neonatal Fc receptor
Pyzik, M., Kozicky, L. K., Gandhi, A. K., & Blumberg, R. S. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00821-1 · Cited by 288
Self-citationA human endothelial cell-based recycling assay for screening of FcRn targeted molecules
Grevys, A., Nilsen, J., Sand, K. M. K., Daba, M. B., Øynebråten, I., Bern, M., McAdam, M. B., Foss, S., Schlothauer, T., Michaelsen, T. E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03061-x · Cited by 98
Self-citationDifferential effects of FcRn antagonists on the subcellular trafficking of FcRn and albumin
Ma, G., Crowley, A. R., Heyndrickx, L., Rogiers, I., Parthoens, E., Van Santbergen, J., Ober, R. J., Bobkov, V., de Haard, H., Ulrichts, P., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.176166 · Cited by 28
Metadata
- Authors
- Pyzik, M., Rath, T., Kuo, T. T., Win, S., Baker, K., Hubbard, J. J., Grenha, R., Gandhi, A., Krämer, T. D., Mezo, A. R., Taylor, Z. S., McDonnell, K., Nienaber, V., Andersen, J. T., Mizoguchi, A., Blumberg, L., Purohit, S., Jones, S. D., Christianson, G., Lencer, W. I., Sandlie, I., Kaplowitz, N., Roopenian, D. C., & Blumberg, R. S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2017-03-22
- Volume
- 114
- Issue
- 14
- Pages
- E2862-E2871
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2598617551
- Cited by
- 102
- References
- 13
- FWCI
- 10.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hepatic FcRn regulates albumin homeostasis and susceptibility to liver injury. https://app.cochat.ai/papers/10.1073/pnas.1618291114
- The paper
- Pyzik, M., Rath, T., Kuo, T. T., Win, S., Baker, K., Hubbard, J. J., Grenha, R., Gandhi, A., Krämer, T. D., Mezo, A. R., Taylor, Z. S., McDonnell, K., Nienaber, V., Andersen, J. T., Mizoguchi, A., Blumberg, L., Purohit, S., Jones, S. D., Christianson, G., . . . Blumberg, R. S. (2017). Hepatic FcRn regulates albumin homeostasis and susceptibility to liver injury. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1618291114
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.